Fundraising FoxRheumasense
1 known investors
Find your way into Rheumasense
Each arrow is one introduction. Sign up to fill in the first one.
44 people can intro you to Jen
Ask John Aballi to introduce you to Jen Skeen
You →John · together at GenomeDx Biosciences Inc. →Jen
Sign up to find every way you can get introduced to Rheumasense
- Your email: who you already know at Rheumasense, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Rheumasense team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Rheumasense develops clinical diagnostic testing technology aimed at transforming the management and care of rheumatoid arthritis. The company is advancing its diagnostic platform toward FDA submission and commercialization.
Founders & leadership
JM
JS
Jen SkeenCEOJen Skeen is CEO of Rheumasense, a clinical diagnostics company developing testing technology for rheumatoid arthritis management. She brings extensive biotechnology and laboratory operations experience, including expertise in molecular diagnostics, regulatory affairs, and commercialization.
Investors · 1
NLClisted by NLCAmsterdam
How we know: NLC's portfolio page · Not right? Tell us
Frequently asked questions
- What does Rheumasense do?
- Rheumasense develops clinical diagnostic testing technology aimed at transforming the management and care of rheumatoid arthritis. The company is advancing its diagnostic platform toward FDA submission and commercialization.
- Who founded Rheumasense?
- Rheumasense was founded by John M. Davis III.
- Who are Rheumasense's investors?
- Rheumasense's investors include NLC.